Jump to navigation
By Abhiram Nandakumar, Reuters | October 13, 2015
By FXHQ.com | October 13, 2015
This morning’s insight includes a busy day of earnings reports, a possible deep dip in the unemployment rate, rising crude prices, and weakness in growth-linked currencies.
By Ransdell Pierson, Reuters | October 13, 2015
Johnson & Johnson reported third-quarter sales well below Wall Street estimates, hurt by the stronger dollar and disappointing demand for its Remicade arthritis drug and its Xarelto blood clot preventer.
By J.W. Jones | April 26, 2013
If both the S&P 500 Index and the 30-year Treasury bond can rally together, what happens if they sell off together?
By Andrew Wilkinson | June 9, 2011
Daily corporate bonds brief including analysis of Johnson & Johnson and Ford
By Andrew Wilkinson | May 23, 2011
Daily corporate bonds brief including analysis of Johnson & Johnson, Bank of America, Barclays and Evergreen Solar